Rare diseases
Investigational molecules
Locations
A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
FranceA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
FranceRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
FranceStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FrancePhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
FranceStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
FrancePhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
FranceA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
FrancePhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
FranceEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
FranceA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
FranceStudy of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
